Results with Lifescozul™
Introduction to the case
Prostate cancer is the most frequent type of cancer among men, and it usually grows slowly and does not spread to other places, but there are cases in which the opposite happens.
Raul's case is one of them. He started with urinary problems and prostate enlargement, when he underwent a medical evaluation in August 2019 he was diagnosed with invasive prostatic adenocarcinoma with metastasis in liver and bone.
The fact that this type of cancer metastasizes to the liver is not very common, very few cases are recorded.
In addition to this, a 6 centimeter tumor was detected in her liver, which increased her risk factors even more.
His doctor prescribed him several traditional medications, chemotherapy and a catheter, but Raul also wanted to complement these treatments with an alternative method, this is when he found LifEscozul Group.
Raul has been treated with LifEscozul (the most effective formulation made with blue scorpion venom) for a year now, let's know the details of his case below.
-
Clinical Data
Raúl Galarza, 65 years old at the beginning of treatment with LifEscozul.
-
Symptomatology
Good general condition, only presented bone pain.
-
Protocol Start
October 2019.
-
Specialist assigned to Grupo LifEscozul™
Dr. Aaron Sarmiento
-
Diagnostics
Prostate cancer (invasive prostatic adenocarcinoma).
Background
Raul was diagnosed in August 2019 with Prostate Cancer with metastasis in bone and liver. It is important to highlight that it is not common for this type of cancer to metastasize to the liver, but it is something that can happen in some cases.
This news shocked him because at that time the cancer was very aggressive and had advanced very fast. In addition, Raul is a person who always kept his medical exams up to date because he is hypertensive and no alterations had been reported, but cancer is a disease that sometimes arrives without warning.
To treat his illness, he was prescribed a hormonal treatment and was additionally placed on a catheter, which caused him to lose 15 kilos of weight.
In addition, Raul was suffering from constant bone pain, so he wanted to try an alternative treatment that would not affect his health and would help him to improve.
While looking for options in September 2019 he found LifEscozul Group.
He sent us all his medical documentation, soon after he was admitted to our Protocol and in October 2019 he started treatment with LifEscozul (escozul, blue scorpion venom, escoazul) with the doses indicated by Dr. Aaron Sarmiento.
Our main goal was to improve his quality of life and control the aggressive progression of his disease.
Evolution with LifEscozul™ and actual results
A FEW DAYS AFTER TAKING LIFESCOZUL
A very important aspect when a patient enters our Protocol, and which also makes a big difference, is that he keeps in constant contact with our Medical Team, something that Raul has done since the beginning of his treatment.
By mid-October 2019 he tells us that the pain in his bones had decreased, so he was needing fewer doses of painkillers.
DECEMBER 2019
In December 2019 he starts chemotherapy sessions, and in this same month he undergoes an operation to remove the probe, at which time Raul reports bone pain again and under the supervision of Dr. Sarmiento the dose of LifEscozul is increased.
He took LifEscozul while receiving chemotherapy, a total of 6 very strong sessions every 21 days, but Raul managed to finish them without side effects.
MAY 2020
One month after finishing the chemotherapy sessions, Raul underwent a complete study of resonance and tomography, to everyone's surprise the liver tumor had disappeared and there were only a few lesions, the joy of Raul and his family was incomparable.
In addition, the pain had diminished.
On the other hand, the bone lesions still persisted but several of them were mistaken for osteoarthritis.
SEPTEMBER 2020
In September 2020 Raul informs us that the liver lesions had disappeared and that he started calcium therapy once a month to strengthen his bones.
He walks normally, regained the 15 kilos of weight he had lost, his appetite has not been affected and he no longer feels pain.
It should be emphasized that during the whole period since he started chemotherapy in December 2019 until May 2020 all his tests have been positive, and the fact that he is hypertensive has not affected him.
When he visited an oncologist he indicated that he is clean of cancer, and when he compared the first image where the 6 centimeter tumor in the liver was clearly visible with the last image where it no longer appears he was surprised.
Currently, our Medical Team is constantly following up with Raul to continue registering his improvement day by day.
Resumen
Raul entered our Protocol in October 2019 with a very negative prognosis: invasive Prostate Cancer with metastasis in liver and bone and a tumor of 6 centimeters.
By his own decision, and to complement his chemotherapy treatment, he seeks an alternative method to help him stop the progression of the disease, this is when he finds LifEscozul Group and in October 2019 he starts treatment with LifEscozul (the most effective formulation made with blue scorpion venom).
A few days later, she began to notice an improvement, and within a few months the results far exceeded our expectations: the 6-centimeter tumor had disappeared, her bone pain decreased, she regained her weight and carries out her activities with total normality.
In addition, she also refers us that her oncologist indicated that she is cancer free.
His disease was progressing very fast and aggressively, but thanks to the combination of conventional treatments with LifEscozul treatment, Raul beat the cancer in time.
The medical accompaniment we provided him at LifEscozul Group and the support of his family were also key aspects that helped his rapid improvement.
Raul is such an energetic person that he wants to give hope to other cancer patients, that was his key to beat the disease: positivism and the desire to move forward.
We are the LifEscozul Group and Results Define Us.
Next case
Natalia Ferreyra
Breast cancer is the most common cancer among women and is the second leading cause of death from cancer. View more
